Phibro Animal Health R&D Spending Growth & History (PAHC)

Phibro Animal Health's r&d spending was $24.6M for fiscal 2026.

View full Phibro Animal Health company overview

Phibro Animal Health annual r&d spending history

Phibro Animal Health annual r&d spending

Fiscal yearPeriod endedR&D spendingChangeGrowth
20262026-06-30$24.6M$825,000+3.48%
20252025-06-30$23.7M−$5.5M−18.73%
20242024-06-30$29.2M$4.8M+19.67%
20232023-06-30$24.4M$3.6M+17.10%
20222022-06-30$20.8M$3.1M+17.30%
20212021-06-30$17.8M$4.0M+29.27%
20202020-06-30$13.7M$1.6M+13.60%
20192019-06-30$12.1M$2.1M+20.95%
20182018-06-30$10.0M$556,000+5.89%
20172017-06-30$9.4M−$1.6M−14.39%
20162016-06-30$11.0M$1.5M+15.96%
20152015-06-30$9.5M$1.3M+15.82%
20142014-06-30$8.2M$1.6M+23.71%
20132013-06-30$6.6M−$551,000−7.66%
20122012-06-30$7.2M

Phibro Animal Health r&d spending trends

Over the last five fiscal years, Phibro Animal Health's r&d spending increased from $17.8M to $24.6M, a change of $6.8M.

About the metric

What research and development spending means

Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.

Calculation and source

SEC-reported R&D expense

TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Phibro Animal Health source filings ↗

Community posts

It’s quiet here.

No posts about PAHC yet. Start the conversation.

Write the first post